ANKRD22 as a novel diagnostic biomarker and immunomodulator in tuberculosis disease: A multi-cohort and clinical validation study
ANKRD22 is a promising diagnostic biomarker for active TB and is linked to an immunosuppressive immune microenvironment, supporting its potential for diagnosis and host‑directed therapy.
Authors
- Qingqing Shan (ORCID: https://orcid.org/0000-0001-5371-9455)
- Daoyan Tang (ORCID: https://orcid.org/0009-0007-6215-4055)
- Yongxian Zhang
- Meng Luo
- Jian-Qing He
Institutions
- Sichuan University (CN)
- West China Hospital of Sichuan University (CN)
Publication Details
- Journal
- Journal of Infection
- Published
- 2026-02-15
- DOI
- https://doi.org/10.1016/j.jinf.2026.106703
- Primary Topic
- Tuberculosis Research and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.00